Influenza vaccination and fetal and neonatal outcomes

Expert Review of Vaccines

Volumn 12, Issue 12, 2013, Pages 1417-1430

  Fell, Deshayne B ^a   Dodds, Linda ^b   MacDonald, Noni E ^b   Allen, Victoria M ^b   McNeil, Shelly ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

epidemiology; H1N1 influenza; influenza; influenza vaccination; pregnancy; pregnancy outcomes; vaccine safety

Indexed keywords

INFLUENZA VACCINE;

ADULT; ADVERSE OUTCOME; APGAR SCORE; CANADA; CASE CONTROL STUDY; CLINICAL PRACTICE; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; FETUS; FETUS DEATH; FETUS MORTALITY; GESTATIONAL AGE; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LOW BIRTH WEIGHT; MALI; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SEASONAL INFLUENZA; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VERY LOW BIRTH WEIGHT;

FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TREATMENT OUTCOME; VACCINATION;

EID: 84887765738     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2013.851607     Document Type: Review

References (66)

1. Skowronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine 27(35), 4754-4770 (2009).
2. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol. 148(11), 1094-1102 (1998).
3. Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176(4), 463-468 (2007).
4. National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2011-2012. Can. Commun. Dis. Rep. 37(ACS-5), 1-55 (2011).
5. Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 59(RR-8), 1-62 (2010).
6. Memoli MJ, Harvey H, Morens DM, Taubenberger JK. Influenza in pregnancy. Influenza Other Respi. Viruses doi:10.1111/irv.12055 (2012) (Epub ahead of print).
7. Steinhoff MC, MacDonald NE. Influenza pandemics-pregnancy, pathogenesis, and perinatal outcomes. JAMA 308(2), 184-185 (2012).
8. Irving WL, James DK, Stephenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107(10), 1282-1289 (2000).
9. Steinhoff MC, Omer SB. A review of fetal and infant protection associated with antenatal influenza immunization. Am. J. Obstet. Gynecol. 207(3 Suppl.), S21-S27 (2012).
10. MacDonald NE, Riley LE, Steinhoff MC. Influenza immunization in pregnancy. Obstet. Gynecol. 114(2), 365-368 (2009).
11. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol. Rev. 28(3), 47-53 (2006).
12. Yudin MH, Salaripour M, Sgro MD. Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. JOGC 31(2), 120-125 (2009).
13. Centers for Disease Control. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women-10 states, 2009-10 influenza season. MMWR 59(47), 1541-1545 (2010).
14. Liu N, Sprague AE, Yasseen AS III et al. Vaccination patterns in pregnant women during the 2009 H1N1 influenza pandemic: a population-based study in Ontario, Canada. Can. J. Public Health 103(5), 353-358 (2012).
15. Gilmour H, Hofmann N. H1N1 vaccination. Health Rep. 21(4), 63-69 (2010).
16. Moro PL, Broder K, Zheteyeva Y et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am. J. Obstet. Gynecol. 205(5), 473-481 (2011).
17. Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev. Vaccines 11(8), 911-921 (2012).
18. Schatz M, Chambers CD, Jones KL, Louik C, Mitchell A. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am. J. Obstet. Gynecol. 204(6 Suppl. 1), s64-s68 (2011).
19. Tamma PD, Ault K, del Rio C et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol. 201(6), 547-552 (2009).
20. Deinard AS, Ogburn P. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am. J. Obstet. Gynecol. 140(3), 240-245 (1981).
21. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am. J. Perinat. 21(6), 333-339 (2004).
22. France EK, Smith-Ray R, McClure D et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch. Pediat. Adol. Med. 160(12), 1277-1283 (2006).
23. Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol. 192(4), 1098-1106 (2005).
24. Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. NEJM 359(15), 1555-1564 (2008).
25. Steinhoff MC, Omer SB, Roy E et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 184(6), 645-653 (2012).
26. Doumbia M, Teguete I, Orenstein EW et al. Rates and causes of serious adverse events in the first 25 weeks of a clinical trial of maternal influenza vaccine during the third trimester in Bamako, Mali. Presented at: 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene. Atlanta, GA, USA, 11-15 November 2012.
27. Adegbola R, Nesin M, Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am. J. Obstet. Gynecol. 207 (3 Suppl.), S28-S32 (2012).
28. Dodds L, Macdonald N, Scott J, Spencer A, Allen VM, McNeil S. The association between influenza vaccine in pregnancy and adverse neonatal outcomes. JOGC 34(8), 714-720 (2012).
29. Omer SB, Goodman D, Steinhoff MC et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med. 8(5), 1-8 (2011).
30. Sheffield JS, Greer LG, Rogers VL et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet. Gynecol. 120(3), 532-537 (2012).
31. Irving SA, Kieke BA, Donahue JG et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet. Gynecol. 121(1), 159-165 (2013).
32. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. NEJM 361(20), 1945-1952 (2009).
33. Broadbent AJ, Subbarao K. Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr. Opin. Virol. 1(4), 254-262 (2011).
34. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 375(9708), 41-82 (2010).
35. Greenberg ME, Lai MH, Hartel GF et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. NEJM 361(25), 2405-2413 (2009).
36. Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 375(9708), 49-55 (2010).
37. Centers for Disease Control. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 58(RR-10), 1-8 (2009).
38. Rasmussen SA, Jamieson DJ. Influenza and pregnancy in the United States: before, during, and after 2009 H1N1. Clin. Obstet. Gynecol. 55(2), 487-497 (2012).
39. Zuccotti G, Pogliani L, Pariani E, Amendola A, Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA 304(21), 2360-2361 (2010).
40. Tsatsaris V, Capitant C, Schmitz T et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann. Intern. Med. 155(11), 733-741 (2011).
41. Ha°berg SE, Trogstad L, Gunnes N et al. Risk of fetal death after pandemic influenza virus infection or vaccination. NEJM 368, 333-340 (2013).
42. Pasternak B, Svanström H, Mølgaard-Nielsen D et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 344, e2794-e2806 (2012).
43. Pasternak B, Svanström H, Mølgaard-Nielsen D et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 308(2), 165-174 (2012).
44. Sammon CJ, Snowball J, McGrogan A, de Vries CS. Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS ONE 7(12), e51734-e51742 (2012).
45. Fell DB, Sprague AE, Liu N et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am. J. Public Health 102(6), e33-e40 (2012).
46. Källén B, Olausson P. Vaccination against H1N1 influenza with Pandemrix(1) during pregnancy and delivery outcome: a Swedish register study. BJOG 119(13), 1583-1590 (2012).
47. Ludvigsson JF, Zugna D, Cnattingius S et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur. J. Epidemiol. 28(7), 579-588 (2013).
48. Heikkinen T, Young J, van Beek E et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am. J. Obstet. Gynecol. 207(3), e1-e8 (2012).
49. Rubinstein F, Micone P, Bonotti A et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 346, f393 (2013).
50. Richards JL, Hansen C, Bredfeldt C et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin. Infect. Dis. 56(9), 1216-1222 (2013).
51. Launay O, Krivine A, Charlier C et al. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study. PLoS ONE 7(12), e52303-e52310 (2012).
52. Lin TH, Lin SY, Lin CH et al. AdimFlu-S (1) influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey. Vaccine 30(16), 2671-2675 (2012).
53. Cantu J, Biggio J, Jauk V, Wetta L, Andrews W, Tita A. Selective uptake of influenza vaccine and pregnancy outcomes. J. Matern-Fetal Neonat. Med. 26(12), 1207-1211 (2013).
54. Conlin AMS, Bukowinski AT, Sevick CJ, DeScisciolo C, Crum-Cianflone NF. Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns. Obstet. Gynecol. 121(3), 511-518 (2013).
55. Jacobson RM, Targonski PV, Poland GA. Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases. Vaccine 25(16), 3165-3169 (2007).
56. Pedersen AT, Ottesen B. Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials-time out for hormone replacement therapy studies? Hum. Reprod. 18(11), 2241-2244 (2003).
57. Hak E, Verheij TJM, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J. Epidemiol. Community Health 56(12), 951-955 (2012).
58. Nelson JC, Jackson ML, Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J. Clin. Epidemiol. 62(7), 687-694 (2009).
59. Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 27(45), 6300-6304 (2009).
60. Campitelli MA, Rosella LC, Stukel TA, Kwong JC. Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 29(2), 240-246 (2010).
61. Hottes TS, Skowronski DM, Hiebert B et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS ONE 6(7), e22618-e22630 (2011).
62. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol. 35(2), 337-344 (2006).
63. Oppermann M, Fritzsche J, Weber-Schoendorfer C et al. A(H1N1) v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 30(30), 4445-4452 (2012).
64. Xu R, Luo Y, Chambers C. Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models. Pharmacoepidemiol. Drug Saf. 21(8), 844-850 (2012).
65. O'Neill MS, Hertz-Picciotto I, Pastore LM, Weatherley BD. Have studies of urinary tract infection and preterm delivery used the most appropriate methods? Paediatr. Perinat. Epidemiol. 17(3), 226-233 (2003).
66. Darrow L, Strickland MJ, Klein M et al. Seasonality of birth and implications for temporal studies of preterm birth. Epidemiology 20(5), 699-706 (2009).